Marker Therapeutics
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$1.24M N/A	$9.00M 625.17%	$3.31M -63.22%	Avg: $12.5M Low: $12.5M High: $12.5M avg. 277.51%	Avg: $7.8M Low: $7.8M High: $7.8M avg. -37.6%	Avg: $37.97M Low: $37.97M High: $37.97M avg. 386.82%
Net Income % change YoY	$-41.87M N/A	$-29.91M 28.55%	$-14.04M 53.04%	Avg: $-32.65M Low: $-11.71M High: $-11.71M avg. -132.48%	Avg: $-41.25M Low: $-10.57M High: $-10.57M avg. -26.32%	Avg: $-5.54M Low: $-5.54M High: $-5.54M avg. 86.54%
EBITDA % change YoY	$-36.31M N/A	$-26.26M 27.67%	$-11.79M 55.10%	Avg: $-12.5M Low: $-12.5M High: $-12.5M avg. -6.00%	Avg: $-7.8M Low: $-7.8M High: $-7.8M avg. 37.6%	Avg: $-37.97M Low: $-37.97M High: $-37.97M avg. -386.82%
EPS % change YoY	-$5.47 N/A	-$3.58 34.55%	-$1.93 46.08%	Avg: -$1.33 Low: -$1.33 High: -$1.33 avg. 31.08%	Avg: -$1.2 Low: -$1.2 High: -$1.2 avg. 9.77%	Avg: -$0.63 Low: -$0.63 High: -$0.63 avg. 47.5%
Operating Expenses % change YoY	$40.71M N/A	$38.95M -4.32%	$17.89M -54.07%	Avg: $208.30M Low: $208.30M High: $208.30M avg. 1064.21%	Avg: $129.98M Low: $129.98M High: $129.98M avg. -37.60%	Avg: $632.78M Low: $632.78M High: $632.78M avg. 386.82%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -24.08% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -11.71M, average is -32.65M and high is -11.71M.

Wall Street analysts forecast annual average revenue growth of 208.91% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $12.5M, average is $12.5M and high is $12.5M.

Wall Street analysts forecast annual average earnings growth of 29.45% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.33, average is -$1.33 and high is $-1.33.